: The AMEDEO Literature Guide

Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Stem Cell Research

Free Subscription

Articles published in Bone Marrow Transplant
Retrieve available abstracts of 297 articles:
HTML format

Single Articles

August 2026

CHIEW XY, Bai L, Wang HF, Zhang F, et al
Incidence and risk factors of Epstein-Barr virus infection and post-transplant lymphoproliferative disorder in paediatric haploidentical allogeneic hematopoietic stem cell transplantation.
Bone Marrow Transplant. 2026 Aug 25. doi: 10.1038/s41409-026-03003.
PubMed Abstract available

WALKER I, Deotare U, Elemary M, Elsawy M, et al
A randomized pilot trial comparing anti-thymocyte globulin with anti-thymocyte globulin plus post transplant cyclophosphamide for prophylaxis against acute and chronic graft versus host disease in matched donor hematopoietic cell transplants - a study
Bone Marrow Transplant. 2026 Aug 21. doi: 10.1038/s41409-026-03024.
PubMed Abstract available

SHIRAISHI K, Shimomura Y, Hosoi H, Fuse K, et al
Prognostic factors of second allogeneic hematopoietic stem cell transplantation for relapsed or refractory myelodysplastic syndromes: nationwide registry analysis.
Bone Marrow Transplant. 2026 Aug 19. doi: 10.1038/s41409-026-03015.
PubMed

LIU J, Wang C, Min H, Chen J, et al
A real-world, multi-center, retrospective study of autologous hematopoietic stem cell transplantation in 33 patients with HIV-associated lymphoma in China (CALL-006 Study).
Bone Marrow Transplant. 2026 Aug 19. doi: 10.1038/s41409-026-02973.
PubMed

BILINSKI J, Jasinski M, Krasnodebska J, Basak GW, et al
Fecal microbiota transplantation in the treatment of acute graft-versus-host disease: A retrospective study performed by the Complications Working Party and Pediatric Diseases Working Party of the EBMT.
Bone Marrow Transplant. 2026 Aug 18. doi: 10.1038/s41409-026-03010.
PubMed Abstract available

USSMANN J, Wall C, Bischof L, Jendro J, et al
Low muscle quality, but not muscle mass, in abdominal CT-scans associates with adverse outcomes in AML patients undergoing an allogeneic stem cell transplantation.
Bone Marrow Transplant. 2026 Aug 13. doi: 10.1038/s41409-026-03005.
PubMed

GOKLEMEZ S, Pavletic SZ, Choo-Wosoba H, Pirsl F, et al
Elevated plasma anandamide levels in sclerotic chronic graft-versus-host disease highlight the endocannabinoid system as a potential therapeutic target.
Bone Marrow Transplant. 2026 Aug 8. doi: 10.1038/s41409-026-03004.
PubMed

RENA JA, Fernandes M, Roa CL, Hamdan M, et al
Improvement of signs of vulvovaginal chronic graft-versus-host disease and genital syndrome of menopause with non-ablative radiofrequency therapy.
Bone Marrow Transplant. 2026 Aug 7. doi: 10.1038/s41409-026-03002.
PubMed

LI X, Wang W, Li R, Luo J, et al
Optimal timing of letermovir prophylaxis after allogeneic hematopoietic stem cell transplantation: insights from a real-world time-varying exposure analysis.
Bone Marrow Transplant. 2026 Aug 4. doi: 10.1038/s41409-026-02993.
PubMed

THYAGU S, Kongtim P
From salvage therapy to survivorship: mapping the late effects of autologous stem cell transplantation in autoimmune disease.
Bone Marrow Transplant. 2026 Aug 4. doi: 10.1038/s41409-026-02927.
PubMed

ZHOU M, Xiao P, Li B, Gao L, et al
Real-world effectiveness and safety of belumosudil in pediatric refractory chronic graft-versus-host disease.
Bone Marrow Transplant. 2026 Aug 1. doi: 10.1038/s41409-026-02997.
PubMed

July 2026

IBRAHIM NH, Dhunlall S, Woolstencroft R, Liu AJ, et al
Vaccination in haematopoietic stem cell transplantation and cellular therapies: consensus, divergence, and uncertainties in global practice.
Bone Marrow Transplant. 2026 Jul 28. doi: 10.1038/s41409-026-02995.
PubMed

SURANA P, Goldfinger M, Mantzaris I, Konopleva M, et al
Graft-versus-host disease prophylaxis with abatacept plus intermediate dose cyclophosphamide for GVHD prophylaxis after peripheral blood stem transplantation: a single institution study.
Bone Marrow Transplant. 2026 Jul 27. doi: 10.1038/s41409-026-03000.
PubMed

MEKINIAN A, Oganesyan A, Peric Z, Labopin M, et al
Secondary autoimmune and inflammatory diseases after allogeneic hematopoietic stem cell transplantation: a retrospective study from the EBMT transplant complications and autoimmune diseases working parties.
Bone Marrow Transplant. 2026 Jul 27. doi: 10.1038/s41409-026-02981.
PubMed Abstract available

ZHANG Z, Xu X, Wen Q, Zhang R, et al
Impacts of IPSS-M and transplant conditioning intensity in allogeneic stem cell transplant for myelodysplastic neoplasms.
Bone Marrow Transplant. 2026 Jul 27. doi: 10.1038/s41409-026-02939.
PubMed

RODRIGUEZ-LOBATO LG, de Daniel A, Carro Arostegui I, Arribas Castro I, et al
Autologous stem cell transplantation in POEMS syndrome: Multicenter real-world treatment patterns and outcomes.
Bone Marrow Transplant. 2026 Jul 25. doi: 10.1038/s41409-026-02984.
PubMed Abstract available

LAZZARI L, Francesio A, Bruno A, Piemontese S, et al
Baseline liver stiffness predicts SOS/VOD after allogeneic hematopoietic stem cell transplantation.
Bone Marrow Transplant. 2026 Jul 24. doi: 10.1038/s41409-026-02999.
PubMed

ELGOHARY G, Alsharif M, El Fakih R, Mohammed Ben Lamine C, et al
Nonmyeloablative and reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation in sickle cell disease: a narrative review of safety, engraftment, and graft-versus-host-disease outcomes in adults and high-risk populations.
Bone Marrow Transplant. 2026 Jul 22. doi: 10.1038/s41409-026-02982.
PubMed Abstract available

CARTA R, De Luca CD, Bertaina V, Gaspari S, et al
Efficacy of blinatumomab for dermatomyositis/SLE overlap syndrome occurring after allogeneic hematopoietic stem cell transplant performed for acute lymphoblastic leukemia.
Bone Marrow Transplant. 2026 Jul 21. doi: 10.1038/s41409-026-02990.
PubMed

BALEYDIER F, Galimard JE, Bernard F, Gonzales F, et al
Is the adult EBMT risk score valid and relevant for hematopoietic stem cell transplantation in children acute leukemia?
Bone Marrow Transplant. 2026 Jul 20. doi: 10.1038/s41409-026-02952.
PubMed Abstract available

REN Y, Zhang R, Chen X, Zhang X, et al
Successful allogeneic hematopoietic stem cell transplantation in children with myeloid malignancies secondary to GATA2 deficiency using decitabine-containing busulfan conditioning.
Bone Marrow Transplant. 2026 Jul 18. doi: 10.1038/s41409-026-02978.
PubMed

PIERRI F, Bagnasco F, Saglio F, Fagioli F, et al
Early inflammatory complications after haploidentical hematopoietic stem cell transplantation with post transplant cyclophosphamide for acute leukemia: a pediatric multicenter experience.
Bone Marrow Transplant. 2026 Jul 18. doi: 10.1038/s41409-026-02976.
PubMed Abstract available

CAVALLARO G, Lazzarotto D, Pavoni C, Valsecchi F, et al
Favorable outcomes after early allogeneic stem cell transplantation in adult early T-cell precursor acute lymphoblastic leukemia treated with the pediatric-inspired GIMEMA LAL1913 program. A Campus ALL study.
Bone Marrow Transplant. 2026 Jul 16. doi: 10.1038/s41409-026-02975.
PubMed

MAULINI M, Bornand A, Simonetta F, Mamez AC, et al
Liver biopsy after allogeneic stem cell transplantation.
Bone Marrow Transplant. 2026 Jul 16. doi: 10.1038/s41409-026-02987.
PubMed

USSMANN J, Jentzsch M, Schwind S, Herling M, et al
Relapse risk after FLAMSA RIC based allogeneic hematopoietic stem cell transplantation in heavily pretreated AML patients.
Bone Marrow Transplant. 2026 Jul 15. doi: 10.1038/s41409-026-02960.
PubMed

LUSSANA F, Rizzuto G, Piciocchi A, Oldani E, et al
Allogeneic stem cell transplantation in adult Ph-like acute lymphoblastic leukemia. Results from two consecutive GIMEMA protocols.
Bone Marrow Transplant. 2026 Jul 8. doi: 10.1038/s41409-026-02966.
PubMed

SWOBODA R, Labopin M, Kroger N, Stelljes M, et al
Fludarabine combined with treosulfan or total body irradiation as a conditioning therapy before allogeneic hematopoietic stem cell transplantation in acute lymphoblastic leukemia. A retrospective matched-pair analysis from the ALWP of the EBMT.
Bone Marrow Transplant. 2026 Jul 8. doi: 10.1038/s41409-026-02932.
PubMed Abstract available

JONDREVILLE L, Nguyen S, Ceballos P, Forcade E, et al
ALLOPLUS: allogeneic hematopoietic stem cell transplantation in children and adult people living with human immunodeficiency virus, a retrospective study of the SFGM-TC.
Bone Marrow Transplant. 2026 Jul 6. doi: 10.1038/s41409-026-02956.
PubMed

June 2026

PEPPER J, Reese JB, Traeger L, Stewart T, et al
A multimodal sexual health intervention among hematopoietic stem cell transplant recipients: mediating effects on quality of life and mood.
Bone Marrow Transplant. 2026 Jun 30. doi: 10.1038/s41409-026-02969.
PubMed

PAHNKE S, Kisch AM, Lenhoff S, Hagglund H, et al
The risk of anxiety and depression in Swedish potential stem cell donors-need for increased psychological evaluation and support?
Bone Marrow Transplant. 2026 Jun 30. doi: 10.1038/s41409-026-02933.
PubMed

RICARD L, Stocker N, Banet A, Brissot E, et al
The role of allogeneic stem cell transplantation in peripheral T-cell lymphoma.
Bone Marrow Transplant. 2026 Jun 29. doi: 10.1038/s41409-026-02962.
PubMed Abstract available

AVENOSO D, Radici V, Leoni A, Skert C, et al
A phase II multicenter prospective study to evaluate the safety and efficacy of myeloablative-dose treosulfan plus fludarabine (FT14) conditioning regimen in allogeneic hematopoietic stem cell transplantation for AML patients aged 40-65 in first compl
Bone Marrow Transplant. 2026 Jun 24. doi: 10.1038/s41409-026-02937.
PubMed Abstract available

NIRMAL G, Chadha V, Verma S, Baby EP, et al
Safety, efficacy and feasibility of GCSF and plerixafor based CD34 mobilization for backup autologous stem cell collection in patients undergoing alternate donor hematopoietic stem cell transplant for sickle cell disease: Take away lessons for gene th
Bone Marrow Transplant. 2026 Jun 24. doi: 10.1038/s41409-026-02948.
PubMed Abstract available

PINERO-PEREZ C, Velasco-Guardado A, Perez-Lopez E, Cortes-Rodriguez M, et al
Fecal calprotectin as a biomarker for the diagnosis of gastrointestinal graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
Bone Marrow Transplant. 2026 Jun 23. doi: 10.1038/s41409-026-02934.
PubMed Abstract available

LERMAN B, Schonland S, Hegenbart U, Sanchorawala V, et al
Autologous stem cell transplantation for AL amyloidosis: a multicenter summary of outcomes 2010-2020.
Bone Marrow Transplant. 2026 Jun 22. doi: 10.1038/s41409-026-02943.
PubMed Abstract available

KANELLOPOULOS A, Labopin M, Spyridonidis A, Nikolousis E, et al
Non-myeloablative versus reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients aged >/=65: a study from the ALWP of EBMT.
Bone Marrow Transplant. 2026 Jun 21. doi: 10.1038/s41409-026-02935.
PubMed Abstract available

OSSAMI SAIDY A, Boumendil A, Dreger P, Stella F, et al
The impact of IPI risk factors on CAR T-cell therapy or allogeneic stem cell transplantation for treatment of relapsed or refractory large B-cell lymphoma (LBCL).
Bone Marrow Transplant. 2026 Jun 19. doi: 10.1038/s41409-026-02913.
PubMed Abstract available

CHENG J, Du J, Gu M, Ruan X, et al
The feasibility of ovarian tissue cryopreservation in selected females after hematopoietic stem cell transplantation.
Bone Marrow Transplant. 2026 Jun 18. doi: 10.1038/s41409-026-02931.
PubMed Abstract available

QUEUDEVILLE M, Kloehn J, Schwietzer YA, Lehmberg K, et al
Combined JAK- and TNFalpha-targeting in severe steroid-refractory graft-versus-host disease in children.
Bone Marrow Transplant. 2026 Jun 12. doi: 10.1038/s41409-026-02926.
PubMed

KATAOKA A, Yoshinaga N, Inoue Y, Toubai T, et al
Prognostic factors and a novel scoring system for allogeneic hematopoietic stem cell transplantation in patients aged 70 years or older: a nationwide registry analysis in Japan.
Bone Marrow Transplant. 2026 Jun 11. doi: 10.1038/s41409-026-02870.
PubMed Abstract available

MELCHOR-MELO OE, Robles-Nasta M, Gomez-Cabrera MA, Alberto-Lopez LJ, et al
Implementation of a supervised outpatient residence to support ambulatory hematopoietic stem cell transplantation: experience from Puebla, Mexico.
Bone Marrow Transplant. 2026 Jun 2. doi: 10.1038/s41409-026-02911.
PubMed

May 2026

BROOKS PT, Minculescu L, Hartling HJ, Teglgaard RS, et al
Early high-resolution immune profiles are associated with survival, relapse and graft-versus-host-disease after allogeneic hematopoietic cell transplantation.
Bone Marrow Transplant. 2026 May 30. doi: 10.1038/s41409-026-02901.
PubMed Abstract available

CASTELLI S, Flaadt T, Schulze F, Thole-Kliesch TM, et al
A pilot study combining primary busulfan-based haploidentical stem cell transplantation with GD2 antibody to treat high-risk neuroblastoma.
Bone Marrow Transplant. 2026 May 29. doi: 10.1038/s41409-026-02912.
PubMed Abstract available

PAVIGLIANITI A, Ngoya M, Peffault de la Tour R, Schroeder T, et al
Outcomes of mixed phenotype acute leukemia undergoing allogeneic stem cell transplantation: a retrospective study of the ALWP of EBMT.
Bone Marrow Transplant. 2026 May 27. doi: 10.1038/s41409-026-02920.
PubMed Abstract available

ALBERT MH, Lankester AC, Wynn R, Gennery AR, et al
Updated EBMT/ESID inborn errors working party guidelines for haematopoietic stem cell transplantation for inborn errors of immunity and metabolism.
Bone Marrow Transplant. 2026 May 22. doi: 10.1038/s41409-026-02906.
PubMed

HE W, Han T, He Y, Zhang Y, et al
Conditioning dose adjustment in obese adult patients with severe aplastic anemia undergoing haploidentical hematopoietic stem cell transplantation: a propensity score-matched analysis.
Bone Marrow Transplant. 2026 May 20. doi: 10.1038/s41409-026-02904.
PubMed

LELAS A, Desnica L, Sabol I, Herak DC, et al
Von Willebrand factor and factor VIII as potential biomarkers for diagnosis and disease monitoring in chronic graft-versus-host disease.
Bone Marrow Transplant. 2026 May 19. doi: 10.1038/s41409-026-02903.
PubMed Abstract available

LUO C, Sun R, Yu U, Liu S, et al
High proportion of peripheral blood and haploidentical stem cell transplantation in Chinese children: a nationwide CCBMTR analysis.
Bone Marrow Transplant. 2026 May 12. doi: 10.1038/s41409-026-02897.
PubMed

JARISCH A, Rotz SJ, Cattoni A, Courbiere B, et al
Fertility preservation in 2026: current landscape in Europe and the United States for children and adolescents undergoing hematopoietic stem cell transplantation-recommendations on behalf of the Westhafen Intercontinental Group.
Bone Marrow Transplant. 2026 May 12. doi: 10.1038/s41409-026-02861.
PubMed Abstract available

WANG M, Luo J, Blaise D, Devillier R, et al
Allogeneic hematopoietic stem cell transplantation in elderly patients with AML and MDS: navigating risks and optimizing outcomes.
Bone Marrow Transplant. 2026 May 8. doi: 10.1038/s41409-026-02872.
PubMed Abstract available

April 2026

PRALONG A, Simon ST, Herling M, Reimer A, et al
Goals-of-care transition after an allogeneic hematopoietic stem-cell transplantation: A cross-sectional survey among hematologists on associated challenges.
Bone Marrow Transplant. 2026 Apr 27. doi: 10.1038/s41409-026-02873.
PubMed

ANDREOZZI F, Galimard JE, Maertens J, Aljurf M, et al
Outcomes of 544 Patients with t(6;9)/DEK::NUP214 acute myeloid leukemia undergoing allogeneic stem cell transplantation: an EBMT study on behalf of the acute leukemia working party (ALWP) and the pediatric diseases working party (PDWP).
Bone Marrow Transplant. 2026 Apr 22. doi: 10.1038/s41409-026-02857.
PubMed Abstract available

JESTIN M, Maury S, Huynh A, Forcade E, et al
Impact of stem cell source in HLA-matched hematopoietic stem cell transplant for acute lymphoblastic leukemia in first complete remission: a study from the GRAALL and the SFGM-TC.
Bone Marrow Transplant. 2026 Apr 16. doi: 10.1038/s41409-026-02837.
PubMed

LIN MH, Gao SN, Huang XJ, Xu LP, et al
Chronic graft-versus-host disease after haploidentical transplantation in aplastic anemia: clinical characteristics, risk factors, and survival outcomes.
Bone Marrow Transplant. 2026 Apr 13. doi: 10.1038/s41409-026-02855.
PubMed Abstract available

TAYLOR AO, Mercer JS, Bradbury CI, Thomas SM, et al
Sociodemographic factors and timing of allogeneic hematopoietic stem cell transplantation in myeloproliferative neoplasms.
Bone Marrow Transplant. 2026 Apr 12. doi: 10.1038/s41409-026-02836.
PubMed

BREYER LM, Wang H, Ma H, Gu D, et al
Hematopoietic stem cells from organ donors lead to long-term multi-lineage engraftment in NSG mice.
Bone Marrow Transplant. 2026 Apr 11. doi: 10.1038/s41409-026-02864.
PubMed

MA XD, Xu ZL, Huang XJ
Bringing the rare into sight: applications of haploidentical stem cell transplantation in the treatment of rare diseases.
Bone Marrow Transplant. 2026 Apr 10. doi: 10.1038/s41409-026-02839.
PubMed Abstract available

HOLMSTROM MO, Minculescu L, Norgaard K, Hartling HJ, et al
Immune reconstitution in patients with myelofibrosis conditioned with a non-myeloablative regimen prior to allogeneic stem cell transplantation.
Bone Marrow Transplant. 2026 Apr 8. doi: 10.1038/s41409-026-02850.
PubMed

CHEN XT, Shi ZC, Wang Y, Zhang XH, et al
Second alternative-donor haploidentical stem cell transplantation enhances survival in patients with myeloid malignancies complicated by posttransplant human leukocyte antigen loss relapse.
Bone Marrow Transplant. 2026 Apr 6. doi: 10.1038/s41409-026-02859.
PubMed

BERGENS MA, Braun M, Johnson EJ, Li Y, et al
Impact of donor age on cognitive recovery in allogenic hematopoietic stem cell transplant patients with mild cognitive impairment.
Bone Marrow Transplant. 2026 Apr 4. doi: 10.1038/s41409-026-02851.
PubMed

GORHAM RB, Sengsayadeth S, Snider CA, Chen CL, et al
Outcomes of hematopoietic stem cell transplantation in patients aged 70 years and older.
Bone Marrow Transplant. 2026 Apr 3. doi: 10.1038/s41409-026-02860.
PubMed

EL CHEIKH J, Tarhini A, Bazarbachi A, Muhsen I, et al
Twelve-year utilization and outcomes of haploidentical hematopoietic stem cell transplantation (HSCT) in the Eastern Mediterranean (EM) region: A multicenter EMBMT registry analysis.
Bone Marrow Transplant. 2026 Apr 1. doi: 10.1038/s41409-026-02849.
PubMed Abstract available

March 2026

RAJU G, Walji M, Nemirovsky D, Devlin S, et al
Correction: Real-world experience of belumosudil and belumosudil/ruxolitinib combination in steroid-refractory chronic graft-versus-host disease.
Bone Marrow Transplant. 2026 Mar 30. doi: 10.1038/s41409-026-02822.
PubMed

MARIOTTI J, De Philippis C, De Gregori S, Giordano L, et al
Reduced relapse rate and improved GVHD/relapse free survival (GRFS) with pharmacokinetics-guided busulfan conditioning regimen for allogeneic stem cell transplantation in adult patients with myeloid hematologic malignancies.
Bone Marrow Transplant. 2026 Mar 29. doi: 10.1038/s41409-026-02826.
PubMed

NAGLER A, Swoboda R, Ferhat AT, Blaise D, et al
Peripheral blood stem cells versus bone marrow graft for non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary acute myeloid leukemia in first complete remission: A study from the ALWP/EBMT.
Bone Marrow Transplant. 2026 Mar 25. doi: 10.1038/s41409-026-02823.
PubMed Abstract available

TAUVERON-JALENQUES U, Aspas Requena G, Gross Z, Tavernier E, et al
Allogeneic hematopoietic stem cell transplantation after azacitidine and venetoclax salvage in relapsed/refractory AML: a multicenter real-world study by the French AURAML group.
Bone Marrow Transplant. 2026 Mar 24. doi: 10.1038/s41409-026-02834.
PubMed Abstract available

MENGHESHA L, Richardson T, Knuever J, Holtick U, et al
Real-world evaluation of belumosudil for chronic ocular graft-versus-host-disease: Efficacy and outcomes.
Bone Marrow Transplant. 2026 Mar 23. doi: 10.1038/s41409-026-02846.
PubMed

GAO L, Li N, Feng L, Zhang X, et al
Is sex chromosome loss a predictive marker for outcome after sex-mismatched allogeneic hematopoietic stem cell transplantation?
Bone Marrow Transplant. 2026 Mar 20. doi: 10.1038/s41409-026-02828.
PubMed Abstract available

SZMIT Z, Lucchini G, Bertaina A, Galimard JE, et al
Impact of acute GvHD severity on survival and disease relapse in pediatric patients undergoing allogeneic stem cell transplantation for acute lymphoblastic leukemia: an analysis based on the EBMT-PDWP registry.
Bone Marrow Transplant. 2026 Mar 19. doi: 10.1038/s41409-026-02797.
PubMed Abstract available

NAZON C, Muninger E, Raus N, Renard C, et al
Hematopoietic stem cell transplantation in pediatric congenital erythropoietic porphyria: a French retrospective multicenter registry study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).
Bone Marrow Transplant. 2026 Mar 18. doi: 10.1038/s41409-026-02824.
PubMed

WU N, Kong J, Lv M, Mo XD, et al
Donor age >/=50 years combined with donor-CI >/=3 identifies a high-risk cohort for adverse outcomes after allogeneic hematopoietic stem cell transplantation in B-cell acute lymphoblastic leukemia.
Bone Marrow Transplant. 2026 Mar 18. doi: 10.1038/s41409-026-02844.
PubMed

ADIL A, Xiang J, Piccirillo N, Harris HG, et al
Advanced deep learning enables prediction of allogeneic stem cell mobilization success.
Bone Marrow Transplant. 2026 Mar 17. doi: 10.1038/s41409-026-02811.
PubMed

VON ASMUTH EGJ, Halkes CJM, Versluis J, Eikema DA, et al
An extraction pipeline for analysis of hematopoietic stem cell transplantation data.
Bone Marrow Transplant. 2026 Mar 10. doi: 10.1038/s41409-026-02818.
PubMed Abstract available

IMBERT DE TREMIOLLES G, Nguyen S, Lebeaux D, de Castro N, et al
Tuberculosis after allogeneic hematopoietic stem cell transplantation: a decade nationwide case-control retrospective study in low-incidence country.
Bone Marrow Transplant. 2026 Mar 10. doi: 10.1038/s41409-026-02800.
PubMed Abstract available

FACCHIN G, Battista ML, Olivieri J, Pasquale R, et al
Bispecific antibodies followed by allogeneic hematopoietic stem cell transplantation as rescue therapy in refractory/relapsed B cell non-Hodgkin lymphoma: a real-life experience.
Bone Marrow Transplant. 2026 Mar 9. doi: 10.1038/s41409-026-02812.
PubMed

MITRUS I, Wilkiewicz M, Fidyk W, Kawulok A, et al
Safe in transit: HSCT clinical outcomes unaffected by stem cell transport time.
Bone Marrow Transplant. 2026 Mar 7. doi: 10.1038/s41409-026-02820.
PubMed

MALARD F, Peric Z, Ruggeri A, Gedde-Dahl T, et al
Chronic graft-versus-host disease: Current situation and unmet needs - A European position statement.
Bone Marrow Transplant. 2026 Mar 7. doi: 10.1038/s41409-026-02817.
PubMed Abstract available

BUG G, Labopin M, Byrne JL, Mielke S, et al
Anti-thymocyte globulin (ATG)- or alemtuzumab-based graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic hematopoietic cell transplantation (HCT) for patients 40 years and older with acute lymphoblastic leukemia in first
Bone Marrow Transplant. 2026 Mar 6. doi: 10.1038/s41409-026-02805.
PubMed Abstract available

ORCHARD K, Langford J, Guy M, Lewis G, et al
Correction: Efficient bone marrow irradiation and low uptake by non-haematological organs with an yttrium-90-anti-CD66 antibody prior to haematopoietic stem cell transplantation.
Bone Marrow Transplant. 2026 Mar 4. doi: 10.1038/s41409-026-02810.
PubMed

February 2026

CEREZO-MARTIN JM, Yanez L, Colorado M, Salas MQ, et al
Real-world experience of treosulfan in allogeneic stem cell transplantation in adult patients with myeloid malignancies. Spanish Group of SCT and Cell Therapy (GETH-TC).
Bone Marrow Transplant. 2026 Feb 25. doi: 10.1038/s41409-026-02804.
PubMed

January 2026

PAN Y, Zuo Y, Cui Q, Liu S, et al
Treatment outcome and efficacy of desensitization strategies for immunized-PTR in hematological malignancies before hematopoietic stem cell transplantation.
Bone Marrow Transplant. 2026 Jan 28. doi: 10.1038/s41409-025-02749.
PubMed Abstract available

MASSOUD R, Klyuchnikov E, Heidenreich S, Manjarres MB, et al
Impact of anti-T-lymphocyte globulin dosing on graft versus host disease in matched sibling peripheral blood stem cell transplantation.
Bone Marrow Transplant. 2026 Jan 21. doi: 10.1038/s41409-025-02761.
PubMed Abstract available

IBRAHIMOVA A, Bidgoli A, Ashraf A, Krogman A, et al
Real world experience using belumosudil for treatment of chronic graft versus host disease in children and young adults.
Bone Marrow Transplant. 2026 Jan 21. doi: 10.1038/s41409-025-02795.
PubMed

WATANABE M, Ohtera S, Kanda J, Hiragi S, et al
Correction: Real-world medical expenses of hematopoietic stem cell transplantation in Japan: a nationwide database study.
Bone Marrow Transplant. 2026 Jan 7. doi: 10.1038/s41409-025-02781.
PubMed

MELE D, Malagola M, Zavaglio F, Grassia G, et al
Human cytomegalovirus-specific T-cell responses and immune-guided strategies as predictors of clinically significant infection in hematopoietic stem cell transplant recipients after letermovir prophylaxis.
Bone Marrow Transplant. 2026 Jan 7. doi: 10.1038/s41409-025-02788.
PubMed

December 2025

SERPENTI F, Galli N, Cavallaro F, Barbullushi K, et al
Danazol treatment for poor graft function after hematopoietic stem cell transplantation: a single centre experience.
Bone Marrow Transplant. 2025 Dec 27. doi: 10.1038/s41409-025-02790.
PubMed

SHEIKH IN, Alqahtani S, Okeleji O, Brown BD, et al
Pre-transplant immunosuppression in pediatric patients undergoing haploidentical stem cell transplant for sickle cell disease is associated with positive outcomes.
Bone Marrow Transplant. 2025 Dec 10. doi: 10.1038/s41409-025-02776.
PubMed

PASVOLSKY O, Marcoux C, Milton DR, Haider AA, et al
Results of delayed or salvage autologous hematopoietic stem cell transplantation for multiple myeloma.
Bone Marrow Transplant. 2025 Dec 5. doi: 10.1038/s41409-025-02771.
PubMed Abstract available

FRANKE GN, Ussmann J, Backhaus D, Nicolay NH, et al
The sequence of 12 Gy total body irradiation and cyclophosphamide does not impact outcomes in AML patients receiving myeloablative allogeneic stem cell transplantation.
Bone Marrow Transplant. 2025 Dec 2. doi: 10.1038/s41409-025-02755.
PubMed

BERTAINA A, Maffeis M, Lucchini G, Galimard JE, et al
Interplay between acute graft-versus-host disease and graft-versus-leukemia effect in pediatric acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: implications for relapse incidence and survival - an EBMT PD
Bone Marrow Transplant. 2025 Dec 1. doi: 10.1038/s41409-025-02748.
PubMed Abstract available

November 2025

SUN Y, Zhu J, Chen J, Jiang E, et al
Incidence and risk factors for graft failure after allogeneic hematopoietic stem cell transplantation in patients with myelofibrosis.
Bone Marrow Transplant. 2025 Nov 25. doi: 10.1038/s41409-025-02746.
PubMed Abstract available

BARBULLUSHI K, Labopin M, Kroger N, Finke J, et al
Outcomes of allogeneic hematopoietic stem cell transplantation from different donor types in primary refractory acute myeloid leukemia: a report from the ALWP of the EBMT.
Bone Marrow Transplant. 2025 Nov 21. doi: 10.1038/s41409-025-02740.
PubMed Abstract available

WATANABE M, Ohtera S, Kanda J, Hiragi S, et al
Real-world medical expenses of hematopoietic stem cell transplantation in Japan: a nationwide database study.
Bone Marrow Transplant. 2025 Nov 15. doi: 10.1038/s41409-025-02753.
PubMed

KURIYAMA K, Watanabe M, Okatani T, Ota S, et al
Outcomes of hematopoietic stem cell transplantation for patients with monomorphic epitheliotropic intestinal T-cell lymphoma: retrospective study from the Adult Lymphoma Working Group of the Japan Society for Transplantation and Cellular Therapy.
Bone Marrow Transplant. 2025 Nov 15. doi: 10.1038/s41409-025-02752.
PubMed

CHOE H, DeFilipp Z
Current therapeutics for sclerotic and fibrotic manifestations of chronic graft-versus-host disease.
Bone Marrow Transplant. 2025 Nov 13. doi: 10.1038/s41409-025-02743.
PubMed Abstract available

ROCHA V, Labopin M, Raiola AM, Devillier R, et al
Use of bone marrow cells is associated with improved outcomes when compared to peripheral blood stem cell after haplo-identical transplants with post transplant cyclophosphamide, a study from of the CTIWP-EBMT.
Bone Marrow Transplant. 2025 Nov 5. doi: 10.1038/s41409-025-02735.
PubMed Abstract available

October 2025

LAZANA I, Gkirkas K, Konstantellos I, Chatzidimitriou C, et al
Low-dose post-transplant cyclophosphamide in combination with low-dose alemtuzumab for graft-versus-host-disease prevention in mismatched unrelated allogeneic stem cell transplantation is associated with improved outcomes and reduced toxicity.
Bone Marrow Transplant. 2025 Oct 23. doi: 10.1038/s41409-025-02736.
PubMed Abstract available

GALAVERNA F, Styczynski J, Ljungman P
Changing scenario in prevention and management of CMV infections in pediatric hematopoietic stem cell transplant patients.
Bone Marrow Transplant. 2025 Oct 22. doi: 10.1038/s41409-025-02739.
PubMed Abstract available

JANSSEN MJM, de Witte MA, Daenen LGM, Verduyn Lunell F, et al
Preserved measles immunity after allogeneic hematopoietic stem cell transplantation in a cohort of mainly alphabeta T-cell-depleted graft recipients.
Bone Marrow Transplant. 2025 Oct 6. doi: 10.1038/s41409-025-02731.
PubMed

RAJU G, Walji M, Nemirovsky D, Devlin S, et al
Real-world experience of belumosudil and belumosudil/ruxolitinib combination in steroid-refractory chronic graft-versus-host disease.
Bone Marrow Transplant. 2025 Oct 4. doi: 10.1038/s41409-025-02721.
PubMed Abstract available

September 2025

GRECO R, Saccardi R, Ponzano M, Badoglio M, et al
BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working party.
Bone Marrow Transplant. 2025 Sep 29. doi: 10.1038/s41409-025-02715.
PubMed Abstract available

ECHECOPAR C, Bueno Sanchez D, Leon Triana O, Molina Angulo B, et al
The use of mesenchymal stromal cells in steroid-refractory graft-versus-host disease after pediatric hematopoietic stem cell transplantation: a report of the Spanish group of stem cell transplantation (Geth).
Bone Marrow Transplant. 2025 Sep 26. doi: 10.1038/s41409-025-02717.
PubMed

TSIRIGOTIS P, Lazana I
Donor-derived malignancy after allogeneic stem cell transplantation: a rare but well recognized complication.
Bone Marrow Transplant. 2025 Sep 26. doi: 10.1038/s41409-025-02725.
PubMed Abstract available

MICHIELSEN LA, de Witte MA, Daenen LGM, Janssen A, et al
Pure white cell aplasia following allogeneic hematopoietic stem cell transplantation.
Bone Marrow Transplant. 2025 Sep 25. doi: 10.1038/s41409-025-02712.
PubMed

LEARDINI D, Roberto M, Roggiani S, Muratore E, et al
Hematopoietic stem cell transplantation disrupts age-related gut microbiota signatures in pediatric and adult recipients.
Bone Marrow Transplant. 2025 Sep 25. doi: 10.1038/s41409-025-02713.
PubMed Abstract available

OTOUKESH S, Amanam I, Yang D, Samuels D, et al
Pulmonary manifestations during neutrophil engraftment in recipients of allogeneic hematopoietic cell transplantation for myelofibrosis.
Bone Marrow Transplant. 2025 Sep 24. doi: 10.1038/s41409-025-02724.
PubMed

VIVEROS-LUGO MA, Cruz-Perez GE, Garcia-Velez D, Chavez-Martinez S, et al
Predicting the response to hematopoietic stem cell transplantation in persons with multiple sclerosis: the significance of an early positive response.
Bone Marrow Transplant. 2025 Sep 20. doi: 10.1038/s41409-025-02707.
PubMed

FUJII T, Sakurai M, Shimizu H, Izumi A, et al
Impact of prior solid tumors and their treatment modality on outcomes after allogeneic hematopoietic stem cell transplantation.
Bone Marrow Transplant. 2025 Sep 15. doi: 10.1038/s41409-025-02718.
PubMed Abstract available

BARTHELEMY C, Jestin M, Brignier A, Parquet N, et al
Early administration of selected CD34 peripheral blood stem cell following bone marrow transplantation to prevent graft rejection: experience in haploidentical transplant for sickle cell disease.
Bone Marrow Transplant. 2025 Sep 12. doi: 10.1038/s41409-025-02685.
PubMed

WEBER D, Meedt E, Ghimire S, Hiergeist A, et al
"The antibiotic paradox" in allogeneic stem cell transplantation.
Bone Marrow Transplant. 2025 Sep 4. doi: 10.1038/s41409-025-02706.
PubMed

August 2025

FOKKEMA C, Appelman MK, Veldhoen N, Spelt A, et al
Mobilization of hematopoietic stem cells using G-CSF with or without cyclophosphamide before autologous stem cell transplantation in patients with newly diagnosed multiple myeloma receiving induction therapy with or without daratumumab.
Bone Marrow Transplant. 2025 Aug 30. doi: 10.1038/s41409-025-02681.
PubMed

DEL PAPA N, Labopin M, Badoglio M, Farge D, et al
Definition of relapse criteria in patients with rapidly progressive systemic sclerosis treated with autologous haemopoietic stem cell transplantation.
Bone Marrow Transplant. 2025 Aug 27. doi: 10.1038/s41409-025-02684.
PubMed

CESARO S, Verheggen I, Tridello G, Styczynski J, et al
A survey on the practices and the management of hemorrhagic cystitis in patients who undergo allogeneic hematopoietic stem cell transplantation, on behalf of the Infectious Diseases Working Party of EBMT.
Bone Marrow Transplant. 2025 Aug 26. doi: 10.1038/s41409-025-02703.
PubMed Abstract available

LI SQ, Xu LP, Wang Y, Zhang XH, et al
Leukemia stem cells for relapse prediction in AML patients receiving allografts: long-term follow-up of a prospective study.
Bone Marrow Transplant. 2025 Aug 23. doi: 10.1038/s41409-025-02699.
PubMed Abstract available

ALEXANDER T, Roldan E, Del Papa N, Farge D, et al
Autologous haematopoietic stem cell transplantation for rheumatic diseases: best practice recommendations from the EBMT Practice Harmonization and Guidelines Committee.
Bone Marrow Transplant. 2025 Aug 20. doi: 10.1038/s41409-025-02695.
PubMed Abstract available

PULANIC D, Peczynski C, Boreland W, Rautenberg C, et al
Chronic Graft-versus-Host disease trends over 30 years - a study by the EBMT transplant complications working party.
Bone Marrow Transplant. 2025 Aug 19. doi: 10.1038/s41409-025-02697.
PubMed Abstract available

CHEN H, Xu LP, Zhang XH, Wang Y, et al
Long-term survival in patients with Philadelphia-chromosome-positive acute lymphoblastic leukemia who relapse after allogeneic hematopoietic stem cell transplantation: a single-center experience.
Bone Marrow Transplant. 2025 Aug 18. doi: 10.1038/s41409-025-02698.
PubMed

WILCKEN H, Kaier K, Meyer T, Waterhouse M, et al
Influence of daytime of allogeneic stem cell transplantation on incidence of acute graft vs. host disease: a retrospective analytical cohort study.
Bone Marrow Transplant. 2025 Aug 2. doi: 10.1038/s41409-025-02689.
PubMed

July 2025

STEPANYANTS V, Li H, Cenin D, Edwards J, et al
Infections in steroid-refractory chronic graft versus host disease patients treated with ruxolitinib, ibrutinib, or belumosudil.
Bone Marrow Transplant. 2025 Jul 31. doi: 10.1038/s41409-025-02690.
PubMed

IACOBELLI S, Schonland S, Koster L, Blaise D, et al
Outcomes following different upfront stem cell transplantation strategies for multiple myeloma: a statistical perspective on behalf of the Chronic Malignancies Working Party of the EBMT.
Bone Marrow Transplant. 2025 Jul 30. doi: 10.1038/s41409-025-02675.
PubMed Abstract available

BATTISTA ML, Facchin G, De Martino M, Chiusolo P, et al
Real-world study in steroid-refractory acute graft versus host disease: Comparison of efficacy and tolerability of ruxolitinib alone or ruxolitinib in association with extracorporeal photopheresis or extracorporeal photopheresis monotherapy.
Bone Marrow Transplant. 2025 Jul 26. doi: 10.1038/s41409-025-02674.
PubMed

MORALES D, Loth G, Colturato VAR, Tavares RB, et al
Outcomes of hematopoietic stem cell transplantation in pediatric acute lymphoblastic leukemia: a multicenter Brazilian cohort study.
Bone Marrow Transplant. 2025 Jul 24. doi: 10.1038/s41409-025-02676.
PubMed Abstract available

HATZAKIS A, Maybury BD, Chaganti S, Stevens A, et al
Allogeneic haematopoietic stem cell transplantation in advanced cutaneous T-cell lymphomas offers curative potential.
Bone Marrow Transplant. 2025 Jul 23. doi: 10.1038/s41409-025-02683.
PubMed

PENACK O, Bacigalupo A, Gavriilaki E, Greinix H, et al
Treatment patterns of extracorporeal photopheresis in steroid-refractory graft versus host disease: A delphi study.
Bone Marrow Transplant. 2025 Jul 22. doi: 10.1038/s41409-025-02687.
PubMed

SIVARAJ D, Bacon W, Long GD, Rizzieri DA, et al
Correction: High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myeloma.
Bone Marrow Transplant. 2025 Jul 21. doi: 10.1038/s41409-025-02663.
PubMed

SHAHZAD M, Mohsin A, Khamees I, Rehman AU, et al
Impact of body mass index on outcomes following allogeneic hematopoietic stem cell transplantation.
Bone Marrow Transplant. 2025 Jul 17. doi: 10.1038/s41409-025-02680.
PubMed

GUO LP, Hu LJ, Mo XD, Sun YQ, et al
Characteristics and prognosis of central nervous system relapse after allogeneic hematopoietic stem cell transplantation in adult patients with leukemia.
Bone Marrow Transplant. 2025 Jul 17. doi: 10.1038/s41409-025-02673.
PubMed Abstract available

RITTER J, Marco T, Angeletti M, Barnett D, et al
Autologous hematopoietic stem cell transplantation in severe, refractory stiff person syndrome: a case series.
Bone Marrow Transplant. 2025 Jul 16. doi: 10.1038/s41409-025-02686.
PubMed

SHI C, Zeng X, Ge J, Qiu Y, et al
Machine learning-based prediction of G-CSF-induced hematopoietic stem cell mobilization outcomes in healthy volunteers.
Bone Marrow Transplant. 2025 Jul 4. doi: 10.1038/s41409-025-02666.
PubMed Abstract available

GIL-MANSO R, Hidalgo Calleja C, Puebla Tornero L, Cabero-Martinez A, et al
Nabiximols oromucosal spray in patients with chronic graft-versus-host disease: effects on sclerodermatous features and refractory muscle cramps.
Bone Marrow Transplant. 2025 Jul 1. doi: 10.1038/s41409-025-02665.
PubMed

June 2025

BEKADJA MA, Niederwieser D, Kharfan-Dabaja MA, El Fakih R, et al
Correction: Non-cryopreserved autologous peripheral blood stem cell transplantation for multiple myeloma and lymphoma in countries with limited resources: practice considerations from the Worldwide Network for Blood and Marrow Transplantation.
Bone Marrow Transplant. 2025 Jun 30. doi: 10.1038/s41409-025-02664.
PubMed

JING Z, Zhao L, Mai Y, Sun P, et al
Hematopoietic stem cell transplantation outcomes in pediatric acquired aplastic anemia with inherited bone marrow failure syndrome-associated genes.
Bone Marrow Transplant. 2025 Jun 25. doi: 10.1038/s41409-025-02671.
PubMed

TURKIEWICZ D, Elmer E, Lenhoff S, Dykes J, et al
Letermovir prophylaxis may increase the risk of graft-versus-host disease after haploidentical hematopoietic stem cell transplantation with alphabeta(+) T cell depleted grafts.
Bone Marrow Transplant. 2025 Jun 10. doi: 10.1038/s41409-025-02642.
PubMed

SAYYED A, Novitzky-Basso I, Remberger M, Clarke S, et al
Prolonged length of stay in high-risk patients undergoing allogeneic stem cell transplantation: a call to action for addressing healthcare challenges.
Bone Marrow Transplant. 2025 Jun 3. doi: 10.1038/s41409-025-02627.
PubMed Abstract available

CAVALLARO G, Lazzarotto D, Pavoni C, Valsecchi F, et al
Outcomes of allogeneic stem cell transplant in adult Philadelphia negative acute lymphoblastic leukemia patients treated with the pediatric-inspired GIMEMA 1913 protocol. A Campus ALL study.
Bone Marrow Transplant. 2025 Jun 2. doi: 10.1038/s41409-025-02632.
PubMed Abstract available

RUEDA-LARA M, Barrera I, Komanduri KV, Pereira D, et al
Psychosocial correlates of failure to complete hematopoietic stem cell transplants in a diverse population.
Bone Marrow Transplant. 2025 Jun 2. doi: 10.1038/s41409-025-02636.
PubMed

May 2025

MENGHESHA L, Tahmaz V, Holtick U, Scheid C, et al
The effect of posttransplant cyclophosphamide on ocular graft-versus-host disease.
Bone Marrow Transplant. 2025 May 30. doi: 10.1038/s41409-025-02628.
PubMed

NAGLER A, Ferhat AT, Kayser S, Eder M, et al
Prognostic significance of cytogenetic risk score in patients with secondary acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-matched unrelated donors: a study from the ALWP /EBMT.
Bone Marrow Transplant. 2025 May 29. doi: 10.1038/s41409-025-02620.
PubMed Abstract available

KUROSAWA S, Kojo K, Yamakawa R, Kato K, et al
Improved non-relapse mortality in allogeneic hematopoietic stem cell transplantation: a long-standing multidisciplinary pursuit at a single center.
Bone Marrow Transplant. 2025 May 20. doi: 10.1038/s41409-025-02625.
PubMed

BATTIPAGLIA G, Labopin M, Kulagin A, Versluis J, et al
Addition of mycophenolate mofetil to a calcineurin inhibitor and post-transplant cyclophosphamide results in lower incidence of extensive chronic graft-versus-host disease in HLA-matched allogeneic hematopoietic stem cell transplantation for acute mye
Bone Marrow Transplant. 2025 May 13. doi: 10.1038/s41409-025-02610.
PubMed Abstract available

DAENEN LGM, van der Wagen LE, Bonneville EF, Lopez-Corral L, et al
The use of MSCs in steroid-refractory acute GvHD in Europe: a survey from the EBMT cellular therapy & immunobiology working party.
Bone Marrow Transplant. 2025;60:708-714.
PubMed Abstract available

April 2025

IBRAHIMOVA A, Khoury R, Jodele S, Grimley M, et al
Abatacept for acute graft versus host disease prophylaxis in children with sickle cell disease patients undergoing HLA identical sibling hematopoietic stem cell transplantation.
Bone Marrow Transplant. 2025 Apr 29. doi: 10.1038/s41409-025-02601.
PubMed Abstract available

PERMINOVA M, Shelikhova L, Klimentova M, Skvortsova Y, et al
Post-transplant cyclophosphamide, abatacept, and vedolizumab to prevent GVHD after hematopoietic stem cells transplantation in children with acute leukemia: results of a prospective trial.
Bone Marrow Transplant. 2025 Apr 25. doi: 10.1038/s41409-025-02566.
PubMed

TARANTINO S, Labopin M, Zeiser R, Stelljes M, et al
Allogeneic stem cell transplantation in de novo core-binding factor acute myeloid leukemia in active disease: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Bone Marrow Transplant. 2025 Apr 23. doi: 10.1038/s41409-025-02596.
PubMed Abstract available

OZTURK G, Yesilipek MA, Akcay A, Uygun V, et al
Effect of genetic mutations on outcomes of stem cell transplantation in children with hemophagocytic lymphohistiocytosis.
Bone Marrow Transplant. 2025 Apr 22. doi: 10.1038/s41409-025-02592.
PubMed Abstract available

CHUMNUMSIRIWATH P, Vittayawacharin P, Ramos-Perez J, Jeyakumar D, et al
Narsoplimab for refractory transplantation-associated thrombotic microangiopathy (TA-TMA) in adult patients receiving allogeneic hematopoietic stem cell transplantation (AHSCT).
Bone Marrow Transplant. 2025 Apr 22. doi: 10.1038/s41409-025-02595.
PubMed

NAIR V, Kathrotiya M, Shirure V, Bhise S, et al
Feasibility and efficacy of partial replacement of post transplantation cyclophosphamide with bendamustine on day +4 for graft versus host disease prophylaxis in patients undergoing allogeneic hematopoietic cell transplantation.
Bone Marrow Transplant. 2025 Apr 21. doi: 10.1038/s41409-025-02581.
PubMed Abstract available

RAVAIOLI F, Colecchia A, Peccatori J, Pagliara D, et al
Diagnostic accuracy of liver stiffness measurement for the diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation (HSCT), the ELASTOVOD STUDY: an investigator-initiated, prospective, multicent
Bone Marrow Transplant. 2025 Apr 19. doi: 10.1038/s41409-025-02570.
PubMed Abstract available

BERGLAND BS, Remberger M, Tjonnfjord GE, Vo CD, et al
Should a young matched unrelated donor be preferred over an older matched related donor in allogeneic stem cell transplantation for acute leukemia and myelodysplastic syndrome?
Bone Marrow Transplant. 2025 Apr 18. doi: 10.1038/s41409-025-02579.
PubMed

BAYOUMY M, Raffa EH, Alharbi AA, Abosoudah I, et al
Outcomes of Hematopoietic Stem Cell Transplantation in children with Sickle Cell Disease: Does donor Sickle cell trait status matter?
Bone Marrow Transplant. 2025 Apr 18. doi: 10.1038/s41409-025-02572.
PubMed

GALEANO S, Bonfim C, Karduss A, Jaimovich G, et al
Results of the Latin American Bone Marrow Transplantation Society (LABMT) activity survey 2019-2022: the impact of the COVID-19 pandemic and the increase in related haploidentical donors.
Bone Marrow Transplant. 2025 Apr 18. doi: 10.1038/s41409-025-02600.
PubMed Abstract available

LETAILLEUR V, Jullien M, Garnier A, Peterlin P, et al
Posaconazole versus fluconazole as primary antifungal prophylaxis for patients at high risk of invasive fungal infections receiving allogeneic hematopoietic stem cell transplantation.
Bone Marrow Transplant. 2025 Apr 16. doi: 10.1038/s41409-025-02589.
PubMed Abstract available

LYSANDROU M, Kefala D, Vinnakota JM, Savvopoulos N, et al
Regulatory T cell therapy for Graft-versus-Host Disease.
Bone Marrow Transplant. 2025 Apr 16. doi: 10.1038/s41409-025-02553.
PubMed Abstract available

VERBEEK AB, von Asmuth EGJ, van den Akker EB, Jansen-Hoogendijk AM, et al
Pre-transplant inflammation and its associations with acute GvHD and mortality in pediatric allogeneic hematopoietic stem cell transplantation patients.
Bone Marrow Transplant. 2025 Apr 15. doi: 10.1038/s41409-025-02583.
PubMed Abstract available

BREHM N, Biavasco F, Clausen J, Jung J, et al
Teduglutide for treatment-refractory severe intestinal acute graft-versus-host disease - a multicenter survey.
Bone Marrow Transplant. 2025 Apr 14. doi: 10.1038/s41409-025-02586.
PubMed Abstract available

BERGENS MA, Lowder YP, Li Y, Johnson EJ, et al
Food insecurity prior to hematopoietic stem cell transplant is associated with malnutrition and worse outcomes.
Bone Marrow Transplant. 2025 Apr 12. doi: 10.1038/s41409-025-02587.
PubMed Abstract available

GONZALEZ VICENT M, Pereto A, Zubicaray J, Molina B, et al
Outcomes in allogeneic hematopoietic stem cell transplantation for Fanconi anemia.
Bone Marrow Transplant. 2025 Apr 12. doi: 10.1038/s41409-025-02591.
PubMed

SENAPATI J, Garcia-Manero G, DiNardo CD, Deshmukh I, et al
Barriers to allogeneic stem cell transplantation in responding patients with TP53-mutated acute myeloid leukemia.
Bone Marrow Transplant. 2025 Apr 11. doi: 10.1038/s41409-025-02590.
PubMed

ORTI G, Dachy G, Graham CE, Peric Z, et al
Less frequent complications following CAR T-cell therapies: hemophagocytic lymphohistiocytosis, graft-versus-host disease, thrombotic microangiopathy, coagulation disorders and secondary malignancies: best practice recommendations from the EBMT Practi
Bone Marrow Transplant. 2025 Apr 9. doi: 10.1038/s41409-025-02567.
PubMed Abstract available

SUREDA A, Pavlovsky A, Haidar D, Kristo F, et al
Real-world outcomes of brentuximab vedotin as consolidation therapy after autologous stem cell transplantation in relapsed/refractory Hodgkin lymphoma: A systematic review and meta-analysis.
Bone Marrow Transplant. 2025 Apr 8. doi: 10.1038/s41409-025-02557.
PubMed Abstract available

ITONAGA H, Fukushima T, Kato K, Muranushi H, et al
Bone marrow versus peripheral blood stem cells as the graft source for allogeneic transplantation from HLA-matched relative donors in adult T-cell leukemia/lymphoma: A nationwide retrospective study by the ATL working group of the Japanese Society for
Bone Marrow Transplant. 2025 Apr 8. doi: 10.1038/s41409-025-02563.
PubMed

LOPEZ-CORRAL L, Blazquez-Goni C, Perez-Lopez E, Martin-Dominguez FM, et al
GvHD prophylaxis with tacrolimus, sirolimus, and mycophenolate mofetil after reduced intensity conditioning hematopoietic stem cell allogeneic transplantation.
Bone Marrow Transplant. 2025 Apr 8. doi: 10.1038/s41409-025-02562.
PubMed Abstract available

LIU J, Mai Y, Jing Z, Zhao L, et al
Protective factors, management and prognosis of mixed chimerism after allogeneic hematopoietic stem cell transplantation for severe aplastic anemia in children.
Bone Marrow Transplant. 2025 Apr 6. doi: 10.1038/s41409-025-02577.
PubMed Abstract available

BARANWAL A, Kassis R, Hassan K, Kutzke J, et al
Outcomes of attenuated dose fludarabine and melphalan based conditioning regimen in patients undergoing allogeneic stem cell transplant: a propensity score-matched analysis.
Bone Marrow Transplant. 2025 Apr 5. doi: 10.1038/s41409-025-02565.
PubMed

PENA M, Martinez DF, Paviglianiti A, Balaguer A, et al
Thiotepa, busulfan and fludarabine conditioning regimen for adult patients with lymphoid malignancies undergoing allogeneic stem cell transplantation: a study on behalf of GETH-TC.
Bone Marrow Transplant. 2025 Apr 2. doi: 10.1038/s41409-025-02559.
PubMed Abstract available

CHEN W, Zhang Y, Guo J, Wu X, et al
The pre-ASCT serum albumin and pre-ASCT dFLC are prognostic markers in renal light chain amyloidosis patients treated with autologous stem cell transplantation.
Bone Marrow Transplant. 2025 Apr 1. doi: 10.1038/s41409-025-02575.
PubMed

MICHONNEAU D, Malard F, Le Grand S, Magro L, et al
Efficacy and safety of belumosudil for treatment of cGVHD: multicenter retrospective analysis of the French cohort of the compassionate use program, on behalf of the French Society of Bone Marrow Transplantation and Cellular Therapy.
Bone Marrow Transplant. 2025 Apr 1. doi: 10.1038/s41409-025-02554.
PubMed Abstract available

March 2025

MINAKATA D, Fujiwara SI, Honda S, Tominaga R, et al
Impact of daratumumab on the development of engraftment syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma.
Bone Marrow Transplant. 2025 Mar 23. doi: 10.1038/s41409-025-02558.
PubMed

SANTORO N, Schmid C, de Witte M, Roeven MWH, et al
Current use of donor lymphocyte infusions after allogenic stem cell transplantation in Europe: a survey on behalf of the cellular therapy and immunobiology working party of the EBMT.
Bone Marrow Transplant. 2025 Mar 23. doi: 10.1038/s41409-025-02555.
PubMed Abstract available

PINANA JL, Mico-Cerda M, Gomez D, Perez A, et al
Early ribavirin reduce RSV symptoms duration in post-allogeneic stem cell transplant: challenges in symptoms duration assessment.
Bone Marrow Transplant. 2025 Mar 22. doi: 10.1038/s41409-025-02549.
PubMed

STORCK TN, Morsink LM, Biswana A, Hazenberg CLE, et al
Donor lymphocyte infusions after HLA-identical hematopoietic stem cell transplantation with post-transplant cyclophosphamide in acute myeloid leukemia patients.
Bone Marrow Transplant. 2025 Mar 19. doi: 10.1038/s41409-025-02552.
PubMed

KLEINSCHMIDT K, Penkivech G, Troeger A, Foell J, et al
alphass T-cell depleted haploidentical stem cell transplantation for pediatric and young adult patients with transfusion-dependent thalassemia.
Bone Marrow Transplant. 2025 Mar 18. doi: 10.1038/s41409-025-02546.
PubMed Abstract available

GAVRIILAKI E, Evangelidis P, Kotsiou N, Sakellari I, et al
Antifungal prescription and stewardship in hematology and hematopoietic stem cell transplantation units worldwide: an international survey of EHA-SWG Infections in Hematology.
Bone Marrow Transplant. 2025 Mar 9. doi: 10.1038/s41409-025-02545.
PubMed

SCHULZ E, Pirsl F, McGraw K, Nousome D, et al
Prevalence of clonal hematopoiesis of indeterminate potential in patients with severe chronic graft-versus-host disease.
Bone Marrow Transplant. 2025 Mar 8. doi: 10.1038/s41409-025-02537.
PubMed

CALVO C, Mornet C, Storey C, Halfon-Domenech C, et al
Adult height and growth hormone therapy in childhood acute lymphoblastic leukemia survivors treated with total body irradiation and hematopoietic stem cell transplantation before puberty.
Bone Marrow Transplant. 2025 Mar 3. doi: 10.1038/s41409-025-02532.
PubMed

ZHEN S, Liu L, Zhang X, Wang J, et al
Increased Epstein-Barr virus reactivation but similar incidence of post-transplant lymphoproliferative disorders due to pre-emptive rituximab therapy following allogeneic hematopoietic stem cell transplantation in the letermovir era for cytomegaloviru
Bone Marrow Transplant. 2025 Mar 3. doi: 10.1038/s41409-025-02542.
PubMed

February 2025

KOLLER PB, Othman T, Yang D, Mokhtari S, et al
Melphalan-based conditioning with post-transplant cyclophosphamide for peripheral blood stem cell transplantation: donor effect.
Bone Marrow Transplant. 2025 Feb 27. doi: 10.1038/s41409-025-02523.
PubMed Abstract available

VIDAL A, Bora C, Jarisch A, Pape J, et al
Impact of haematopoietic stem cell transplantation for benign and malignant haematologic and non-haematologic disorders on fertility: a systematic review and meta-analysis.
Bone Marrow Transplant. 2025 Feb 26. doi: 10.1038/s41409-025-02520.
PubMed Abstract available

MUCHTAR E, Dispenzieri A, Sanchorawala V, Hassan H, et al
A model for predicting day-100 stem cell transplant-related mortality in AL amyloidosis.
Bone Marrow Transplant. 2025 Feb 24. doi: 10.1038/s41409-025-02535.
PubMed Abstract available

RANDI BA, Higashino HR, Ponzio V, Abdala E, et al
COVID-19 prior to hematopoietic stem cell transplantation increases the risk of acute graft-versus-host disease but does not affect overall mortality.
Bone Marrow Transplant. 2025 Feb 21. doi: 10.1038/s41409-025-02536.
PubMed

LIN MH, Huang XJ, Xu LP, Wang Y, et al
The haematopoietic cell transplantation comorbidity index predicts clinical outcomes for severe aplastic anaemia patients after haploidentical haematopoietic stem cell transplantation.
Bone Marrow Transplant. 2025 Feb 13. doi: 10.1038/s41409-025-02513.
PubMed Abstract available

ZHOU J, Wang F, Yang S, Zhang Y, et al
Survival outcomes between haploidentical stem cell transplantation and chemotherapy for blastic plasmacytoid dendritic cell neoplasm.
Bone Marrow Transplant. 2025 Feb 12. doi: 10.1038/s41409-025-02528.
PubMed Abstract available

SANZ J, Labopin M, Versluis J, Blaise D, et al
Cytogenetic and molecular risk-driven conditioning intensity in acute myeloid leukemia patients undergoing stem cell transplantation with post-transplant cyclophosphamide: a study from the acute leukemia working party of the EBMT.
Bone Marrow Transplant. 2025 Feb 12. doi: 10.1038/s41409-025-02527.
PubMed Abstract available

MODI B, Ngo D, Chen J, Yang D, et al
Belumosudil for the treatment of chronic graft-versus-host disease: a single center real-world experience.
Bone Marrow Transplant. 2025 Feb 4. doi: 10.1038/s41409-024-02498.
PubMed

TAN JY, Koh LP, Woon YK, Heng KK, et al
A formula using day 4 parameters to predict next-day peripheral blood stem cell yield in healthy haematopoietic stem cell donors.
Bone Marrow Transplant. 2025 Feb 3. doi: 10.1038/s41409-024-02503.
PubMed

January 2025

RODRIGUES AM, Fernandes JF, Gregianin L, Nichele S, et al
Hematopoietic stem cell transplantation in inborn errors of metabolism-a retrospective analysis on behalf of the pediatric disease working party from the Brazilian Society of Bone Marrow Transplantation and Cellular Therapy.
Bone Marrow Transplant. 2025 Jan 26. doi: 10.1038/s41409-025-02512.
PubMed Abstract available

SINDONI MM, Limido F, Toso A, Lucchini G, et al
aGvHDtrackR and cGvHDtrackR: shiny applications for graft versus host disease management and clinical data collection.
Bone Marrow Transplant. 2025 Jan 9. doi: 10.1038/s41409-025-02509.
PubMed Abstract available

WANG Q, Liu M, Zhang S, Gao L, et al
Letermovir prophylaxis for cytomegalovirus in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation.
Bone Marrow Transplant. 2025 Jan 7. doi: 10.1038/s41409-024-02502.
PubMed

HUANG XB, Yang X, Li CL, Zhang R, et al
Correction: Haploidentical hematopoietic stem cell transplantation for hematologic malignancies: a novel conditioning regimen with anti-T lymphocyte immunoglobulin instead of anti-thymocyte globulin for in vivo T cell depletion.
Bone Marrow Transplant. 2025 Jan 6. doi: 10.1038/s41409-024-02470.
PubMed

December 2024

YU F, Niu J, Yang J, Hou J, et al
Optimal timing and impact of allogeneic peripheral blood stem cell transplantation in adult T-cell lymphoblastic lymphoma: insights from a large cohort multi-center real-world study in Shanghai.
Bone Marrow Transplant. 2024 Dec 20. doi: 10.1038/s41409-024-02500.
PubMed Abstract available

BRIJS J, Peczynski C, Boreland W, Cuoghi A, et al
Immune checkpoint inhibitors therapy for solid organ malignancies after allogeneic hematopoietic stem cell transplantation: a retrospective study from the EBMT Transplant Complications Working Party.
Bone Marrow Transplant. 2024 Dec 13. doi: 10.1038/s41409-024-02497.
PubMed

FALCO-ROGET A, Raiola AM, Balletto E, Varaldo R, et al
Pre-engraftment bloodstream infection after allogeneic haematopoietic cell transplant: 18-year trends in aetiology, resistance and mortality.
Bone Marrow Transplant. 2024 Dec 11. doi: 10.1038/s41409-024-02494.
PubMed Abstract available

ESCAMILLA-GOMEZ V, Garcia Gutierrez V, Alcalde-Mellado P, Astibia-Mahillo B, et al
Ruxolitinib in acute and chronic graft-versus-host disease: real life long-term experience in a multi-center study for adult and pediatric patients, on behalf of the GETH-TC.
Bone Marrow Transplant. 2024 Dec 11. doi: 10.1038/s41409-024-02483.
PubMed Abstract available

MURATORE E, Gambuti G, Leardini D, Baccelli F, et al
The EASIX score as a predictor of sinusoidal obstruction syndrome and nonrelapse mortality in paediatric patients receiving allogeneic haematopoietic stem cell transplantation.
Bone Marrow Transplant. 2024 Dec 10. doi: 10.1038/s41409-024-02489.
PubMed Abstract available

GRIEB N, Oeser A, Ferle M, Hanke F, et al
Single versus tandem autologous stem cell transplantation in newly diagnosed multiple myeloma.
Bone Marrow Transplant. 2024 Dec 5. doi: 10.1038/s41409-024-02490.
PubMed Abstract available

SUN J, Zhang YC, Wei J, Xu YJ, et al
Outcomes of allogeneic hematopoietic stem cell transplantation versus intensive chemotherapy in patients with myeloid sarcoma: a nationwide representative multicenter study.
Bone Marrow Transplant. 2024 Dec 2. doi: 10.1038/s41409-024-02485.
PubMed Abstract available

November 2024

GIAMMARCO S, Maggi R, Di Marino L, Chiusolo P, et al
The BLIND study: blinatumomab and DLI approach for management of B-ALL relapse after allogeneic stem cell transplantation. A multicentric Italian experience.
Bone Marrow Transplant. 2024 Nov 21. doi: 10.1038/s41409-024-02475.
PubMed

GIAMMARCO S, Limongiello MA, Di Marino L, Metafuni E, et al
The role of daratumumab in complications post-allogeneic hematopoietic stem cell transplantation: a single-center prospective study on PRCA and AIHA.
Bone Marrow Transplant. 2024 Nov 20. doi: 10.1038/s41409-024-02479.
PubMed Abstract available

MAINGUY A, Soussain C, Touitou V, Bennedjai A, et al
High-dose chemotherapy with autologous haematopoietic stem cell transplantation in patients with isolated vitreoretinal lymphoma: a LOC network study.
Bone Marrow Transplant. 2024 Nov 19. doi: 10.1038/s41409-024-02477.
PubMed Abstract available

CHIN MM, Tamaresis JS, Johnston LJ, Lowsky R, et al
Belumosudil combination therapy for chronic graft-versus-host-disease in real-world clinical practice.
Bone Marrow Transplant. 2024 Nov 18. doi: 10.1038/s41409-024-02476.
PubMed

MOLINOS-QUINTANA A, Martinez-Cibrian N, Alonso-Saladrigues A, Galan-Gomez V, et al
Successful allogeneic CD34(+) hematopoietic stem cell boost for prolonged cytopenias following CAR T-cell therapy in B-cell acute lymphoblastic leukemia. On behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC).
Bone Marrow Transplant. 2024 Nov 17. doi: 10.1038/s41409-024-02473.
PubMed

LI SQ, Yu CZ, Xu LP, Wang Y, et al
Pretransplantation risk factors for positive MRD after allogeneic stem cell transplantation in AML patients: a prospective study.
Bone Marrow Transplant. 2024 Nov 16. doi: 10.1038/s41409-024-02466.
PubMed Abstract available

XU LP, Lu PH, Wu DP, Huang H, et al
Correction: Hematopoietic stem cell transplantation activity in China 2022-2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese Blood and Marrow Transplantation Registry Group.
Bone Marrow Transplant. 2024 Nov 15. doi: 10.1038/s41409-024-02438.
PubMed

MAMEZ AC, Pradier A, Morin S, Giannotti F, et al
Utility of the 2024 best practice recommendations from the EBMT Cellular Therapy and Immunobiology Working Party for use of donor lymphocyte infusions after allogeneic hematopoietic stem cell transplantation.
Bone Marrow Transplant. 2024 Nov 15. doi: 10.1038/s41409-024-02458.
PubMed

JEKER B, Thalmann L, Bacher U, Nilius H, et al
Comparing stem cell mobilization with chemotherapy and cytokine (G-CSF) versus cytokine alone in myeloma patients (MOCCCA): a randomized phase II, open-label, non-inferiority trial.
Bone Marrow Transplant. 2024 Nov 15. doi: 10.1038/s41409-024-02468.
PubMed Abstract available

SEVER M, Drozd-Sokolowska J, Gras L, Koster L, et al
Satisfactory outcomes following a second autologous hematopoietic cell transplantation for multiple myeloma in poor stem cell mobilizers: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT.
Bone Marrow Transplant. 2024 Nov 12. doi: 10.1038/s41409-024-02460.
PubMed Abstract available

LI L, Chen Y, Chen T, Xu Y, et al
Mismatched unrelated donors allogeneic hematopoietic stem cell transplantation with antithymocyte globulin for hematological malignancies: a multicenter retrospective study in China.
Bone Marrow Transplant. 2024 Nov 8. doi: 10.1038/s41409-024-02454.
PubMed Abstract available

ALEXANDER T, Badoglio M, Labopin M, Daikeler T, et al
Monitoring and management of CMV and EBV after autologous haematopoietic stem cell transplantation for autoimmune diseases: a survey of the EBMT Autoimmune Diseases Working party (ADWP).
Bone Marrow Transplant. 2024 Nov 7. doi: 10.1038/s41409-024-02461.
PubMed

MAHMOUDJAFARI Z, Bhatt V, Galvin J, Xue Z, et al
Impact of cytopenias and early versus late treatment with ruxolitinib in patients with steroid-refractory acute or chronic graft-versus-host disease.
Bone Marrow Transplant. 2024 Nov 6. doi: 10.1038/s41409-024-02445.
PubMed Abstract available

October 2024

ZHANG ZL, Tong J, Lu RN, Scutt AM, et al
Retraction Note: Therapeutic potential of non-adherent BM-derived mesenchymal stem cells in tissue regeneration.
Bone Marrow Transplant. 2024 Oct 24. doi: 10.1038/s41409-024-02441.
PubMed

JUNEJA M, Prabahran A, Rawicki M, Chee LCY, et al
The economic cost of care in poor graft function following allogeneic stem cell transplantation.
Bone Marrow Transplant. 2024 Oct 24. doi: 10.1038/s41409-024-02452.
PubMed

WANG Y, Gao WH, Wang LN, Wang L, et al
Post-transplant cyclophosphamide with post-engraftment anti-thymocyte globulin reduce moderate to severe chronic graft-versus-host disease in peripheral stem cell transplantation from HLA-matched unrelated and haploidentical donors.
Bone Marrow Transplant. 2024 Oct 22. doi: 10.1038/s41409-024-02436.
PubMed Abstract available

AVIGAN ZM, Arinsburg S, Pan D, Mark T, et al
Author Correction: Mobilization strategies with and without plerixafor for autologous stem cell transplant in patients with multiple myeloma.
Bone Marrow Transplant. 2024 Oct 18. doi: 10.1038/s41409-024-02442.
PubMed

ALSULIMAN T, Psimaras D, Stocker N, Sestili S, et al
Autologous hematopoietic stem cell transplantation in a patient with multi-refractory stiff person syndrome.
Bone Marrow Transplant. 2024 Oct 17. doi: 10.1038/s41409-024-02440.
PubMed

HUANG XB, Yang X, Li CL, Zhang R, et al
Haploidentical hematopoietic stem cell transplantation for hematologic malignancies: a novel conditioning regimen with anti-T lymphocyte immunoglobulin instead of anti-thymocyte globulin for in vivo T cell depletion.
Bone Marrow Transplant. 2024 Oct 14. doi: 10.1038/s41409-024-02433.
PubMed Abstract available

YALCIN K, Uygun V, Ozturk Hismi B, Celen S, et al
Hematopoietic stem cell transplantation in children with mucopolysaccharidosis IVA: single center experience.
Bone Marrow Transplant. 2024 Oct 14. doi: 10.1038/s41409-024-02439.
PubMed Abstract available

BEKADJA MA, Niederwiser D, Kharfan-Dabaja MA, El Fakih R, et al
Non-cryopreserved autologous peripheral blood stem cell transplantation for multiple myeloma and lymphoma in countries with limited resources: practice considerations from the Worldwide Network for Blood and Marrow Transplantation.
Bone Marrow Transplant. 2024 Oct 7. doi: 10.1038/s41409-024-02431.
PubMed Abstract available

SCHNEIDEWIND L, Neumann T, Peters N, Kranz J, et al
Correction: Significance of men's health in long-term survivors of allogeneic stem cell transplantation.
Bone Marrow Transplant. 2024 Oct 4. doi: 10.1038/s41409-024-02415.
PubMed

BERTUGLIA G, Garibaldi B, Casson A, Sarina B, et al
Impact of daratumumab on collection and engraftment in multiple myeloma patients undergoing hematopoietic stem cell mobilization with G-CSF plus on-demand plerixafor.
Bone Marrow Transplant. 2024 Oct 4. doi: 10.1038/s41409-024-02432.
PubMed

September 2024

SHIMOMURA Y, Kitamura T, Sugita J, Terao T, et al
Impact of donor type on the outcomes of acute graft versus host disease to systemic corticosteroid therapy.
Bone Marrow Transplant. 2024 Sep 30. doi: 10.1038/s41409-024-02424.
PubMed Abstract available

BAYOUMY M, Almasari A, Orabe A, Shihata N, et al
Impact of JACIE accreditation on safety of patient care: healthcare providers perspective from a tertiary care stem cell transplant center in Saudi Arabia.
Bone Marrow Transplant. 2024 Sep 28. doi: 10.1038/s41409-024-02387.
PubMed

XU LP, Lu PH, Wu DP, Huang H, et al
Hematopoietic stem cell transplantation activity in China 2022-2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese Blood and Marrow Transplantation Registry Group.
Bone Marrow Transplant. 2024 Sep 25. doi: 10.1038/s41409-024-02419.
PubMed Abstract available

PEDERSEN LL, Gerbek T, Sorum ME, Muhic E, et al
Dietary intake and risk of metabolic syndrome in long-term survivors of pediatric allogeneic hematopoietic stem cell transplantation.
Bone Marrow Transplant. 2024 Sep 18. doi: 10.1038/s41409-024-02412.
PubMed Abstract available

ALDEBERT C, Fahd M, Galimard JE, Ghemlas IA, et al
Outcomes of patients undergoing allogeneic haematopoietic stem cell transplantation for congenital amegakaryocytic thrombocytopenia; a study on behalf of the PDWP of the EBMT.
Bone Marrow Transplant. 2024 Sep 18. doi: 10.1038/s41409-024-02416.
PubMed Abstract available

DUARTE GC, Ladvanszky L, Atkinson G, Burns M, et al
Post-thaw CD34+ cell recovery likely degraded under extreme graft platelet concentrations.
Bone Marrow Transplant. 2024 Sep 16. doi: 10.1038/s41409-024-02409.
PubMed Abstract available

URIA-OFICIALDEGUI ML, Quintero V, Benitez-Carabante MI, Bueno D, et al
Accurate donor and recipient selection and a short time to transplant offer excellent outcomes in upfront hematopoietic stem cell transplantation from matched unrelated donors for pediatric severe aplastic anemia and refractory cytopenia of childhood.
Bone Marrow Transplant. 2024 Sep 3. doi: 10.1038/s41409-024-02406.
PubMed

August 2024

ZHANG H, Guo W, Wang J, Lu N, et al
Impact of bone marrow fibrosis on outcomes of allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia.
Bone Marrow Transplant. 2024 Aug 27. doi: 10.1038/s41409-024-02402.
PubMed Abstract available

SILFVERBERG T, Zjukovskaja C, Noui Y, Carlson K, et al
BEAM or cyclophosphamide in autologous haematopoietic stem cell transplantation for relapsing-remitting multiple sclerosis.
Bone Marrow Transplant. 2024 Aug 26. doi: 10.1038/s41409-024-02397.
PubMed Abstract available

XIE Y, Kazakova V, Weeks LD, Gerber JM, et al
Effects of donor-engrafted clonal hematopoiesis in allogeneic and autologous stem cell transplantation: a systematic review and meta-analysis.
Bone Marrow Transplant. 2024 Aug 25. doi: 10.1038/s41409-024-02403.
PubMed Abstract available

ASENSI CANTO P, Gomez-Segui I, Montoro J, Villalba Montaner M, et al
Incidence, risk factors and therapy response of acute graft-versus-host disease after myeloablative hematopoietic stem cell transplantation with posttransplant cyclophosphamide.
Bone Marrow Transplant. 2024 Aug 24. doi: 10.1038/s41409-024-02391.
PubMed Abstract available

STEWART C, Owen C, Shafey M, Perry S, et al
Reappraisal of autologous stem cell transplantation for transformed indolent lymphoma in the bendamustine era.
Bone Marrow Transplant. 2024 Aug 20. doi: 10.1038/s41409-024-02399.
PubMed

NAGLER A, Labopin M, Swoboda R, Blaise D, et al
Young (<35 years) haploidentical versus old (>/=35 years) mismatched unrelated donors and vice versa for allogeneic stem cell transplantation with post-transplant cyclophosphamide in patients with acute myeloid leukemia in first remission: a study on
Bone Marrow Transplant. 2024 Aug 18. doi: 10.1038/s41409-024-02400.
PubMed Abstract available

JANSCAK M, Stelmes A, van den Berg J, Heim D, et al
Influence of comorbidities on outcome in 1102 patients with an allogeneic hematopoietic stem cell transplantation.
Bone Marrow Transplant. 2024 Aug 13. doi: 10.1038/s41409-024-02395.
PubMed Abstract available

BEER SA, Mohle R, Tabatabai G, Merle DA, et al
Clinical relevance of brain MRI changes in primary central nervous system lymphoma after high-dose-chemotherapy and autologous stem cell transplantation.
Bone Marrow Transplant. 2024 Aug 9. doi: 10.1038/s41409-024-02382.
PubMed Abstract available

DEN HARTOG E, Lindemans CA, Fiocco M, Tissing WJE, et al
Physical performance before and after hematopoietic stem cell transplantation in pediatric patients: a potential role for prehabilitation.
Bone Marrow Transplant. 2024 Aug 8. doi: 10.1038/s41409-024-02390.
PubMed Abstract available

AL HAMED R, Labopin M, Wu D, Gedde-Dahl T, et al
Allogeneic stem cell transplantation in de novo core-binding factor acute myeloid leukemia in first complete remission: data from the EBMT.
Bone Marrow Transplant. 2024 Aug 2. doi: 10.1038/s41409-024-02373.
PubMed Abstract available

LIU L, Han B, Zhang Y, Lei M, et al
First-line treatment of severe aplastic anemia: immunosuppressive therapy plus eltrombopag versus haploidentical hematopoietic stem cell transplantation, a multicenter prospective study.
Bone Marrow Transplant. 2024 Aug 1. doi: 10.1038/s41409-024-02377.
PubMed Abstract available

July 2024

AVIGAN ZM, Arinsburg S, Pan D, Mark T, et al
Mobilization strategies with and without plerixafor for autologous stem cell transplant in patients with multiple myeloma.
Bone Marrow Transplant. 2024 Jul 31. doi: 10.1038/s41409-024-02385.
PubMed Abstract available

VADAKKEL G, Eng S, Proli A, Ponce DM, et al
Updates in chronic graft-versus-host disease: novel treatments and best practices in the current era.
Bone Marrow Transplant. 2024 Jul 31. doi: 10.1038/s41409-024-02370.
PubMed Abstract available

HUSSEIN-AGHA R, Kannengiesser C, Lainey E, Marcais A, et al
Alemtuzumab-based conditioning regimen before hematopoietic stem cell transplantation in patients with short telomere syndromes: a retrospective study of the SFGM-TC.
Bone Marrow Transplant. 2024 Jul 30. doi: 10.1038/s41409-024-02381.
PubMed Abstract available

WANG L, Gao W, Wang L, Jiang J, et al
Impact of graft CD34+ cell counts on hematological recovery in patients receiving post-transplant cyclophosphamide prophylaxis.
Bone Marrow Transplant. 2024 Jul 27. doi: 10.1038/s41409-024-02371.
PubMed

WANG J, Luo Y, Jia C, Yang J, et al
Successful use of defibrotide to treat allogeneic hematopoietic stem cell transplantation associated thrombotic microangiopathy in pediatric patients: report from Chinese single center.
Bone Marrow Transplant. 2024 Jul 23. doi: 10.1038/s41409-024-02368.
PubMed

ESTEVE M, Albert E, Gimenez E, Colomer E, et al
Assessment of Cytomegalovirus DNA doubling time and virus-specific T-cell responses in the management of CMV infection in allogeneic hematopoietic stem cell transplant recipients undergoing Letermovir prophylaxis.
Bone Marrow Transplant. 2024 Jul 20. doi: 10.1038/s41409-024-02376.
PubMed

TSAKIRIS DA, Gavriilaki E, Chanou I, Meyer SC, et al
Hemostasis and complement in allogeneic hematopoietic stem cell transplantation: clinical significance of two interactive systems.
Bone Marrow Transplant. 2024 Jul 14. doi: 10.1038/s41409-024-02362.
PubMed Abstract available

CHOI EJ, Han JH, Park H, Park HS, et al
Lower incidence of acute graft-versus-host disease with post-transplantation cyclophosphamide compared to anti-thymocyte globulin in higher-risk myelodysplastic syndrome.
Bone Marrow Transplant. 2024 Jul 8. doi: 10.1038/s41409-024-02364.
PubMed

June 2024

YU Y, Chen W, Fu H, Shi J, et al
Risk factors and long-term outcomes for human herpesvirus 6 encephalitis in the early period after allogeneic stem cell transplantation.
Bone Marrow Transplant. 2024 Jun 27. doi: 10.1038/s41409-024-02332.
PubMed Abstract available

SANZ MA, Montoro J, Balaguer-Rosello A, Chorao P, et al
Longitudinal outcome over four decades of allogeneic stem cell transplantation: a single center experience.
Bone Marrow Transplant. 2024 Jun 25. doi: 10.1038/s41409-024-02319.
PubMed Abstract available

MARRERO-CEPEDA C, Caballero-Velazquez T, Garcia-Canale S, Martin-Dominguez F, et al
Monocytosis as prognostic factor for chronic graft versus host disease.
Bone Marrow Transplant. 2024 Jun 22. doi: 10.1038/s41409-024-02333.
PubMed

KELKAR AH, Kerssens C, Groblewski N, Clancy D, et al
Human-in-the-loop avatar chatbot shows promise in supporting hematopoietic stem cell transplantation patients.
Bone Marrow Transplant. 2024 Jun 20. doi: 10.1038/s41409-024-02334.
PubMed

ZHU J, Xu M, Ye Y, Ru Y, et al
Haploidentical-cord blood stem cell transplantation versus haploidentical stem cell transplantation for non-CR acute leukemia patients: a multicenter study.
Bone Marrow Transplant. 2024 Jun 19. doi: 10.1038/s41409-024-02335.
PubMed

SCHOEMANS H, Burns LJ, Liptrott SJ, Murray J, et al
Patient engagement in hematopoietic stem cell transplantation and cell therapy: a survey by the EBMT patient engagement task force & transplantation complications working party.
Bone Marrow Transplant. 2024 Jun 18. doi: 10.1038/s41409-024-02290.
PubMed Abstract available

BOULKROUN H, Lacotte E, Angoso M, Dalle JH, et al
Late stenosis of the small intestine and colon, an atypical feature of chronic graft-versus-host disease. National retrospective study in French pediatric allograft centers.
Bone Marrow Transplant. 2024 Jun 17. doi: 10.1038/s41409-024-02330.
PubMed

STEINER N, Massoud R, Klyuchnikov E, Gagelmann N, et al
Anti-T-lymphocyte globulin (ATLG) compared to post-transplant cyclophosphamide as GvHD prophylaxis in ALL patients undergoing allogeneic stem cell transplantation.
Bone Marrow Transplant. 2024 Jun 14. doi: 10.1038/s41409-024-02328.
PubMed Abstract available

AVENOSO D, Lionel S, Maraj A
Second allogeneic haematopoietic stem cell transplant conditioned with treosulfan and fludarabine is associated with encouraging overall survival and transplant related mortality in late relapse of myeloid malignancies.
Bone Marrow Transplant. 2024 Jun 13. doi: 10.1038/s41409-024-02329.
PubMed

ORCHARD K, Langford J, Guy M, Lewis G, et al
Efficient bone marrow irradiation and low uptake by non-haematological organs with an yttrium-90-anti-CD66 antibody prior to haematopoietic stem cell transplantation.
Bone Marrow Transplant. 2024 Jun 12. doi: 10.1038/s41409-024-02317.
PubMed Abstract available

MARTINEZ-MUNOZ ME, Payares-Herrera C, Lipperheide I, Malo de Molina R, et al
Mesenchymal stromal cell therapy for COVID-19 acute respiratory distress syndrome: a double-blind randomised controlled trial.
Bone Marrow Transplant. 2024;59:777-784.
PubMed Abstract available

May 2024

SINGH RB, Cho W, Liu C, Naderi A, et al
Immunopathological mechanisms and clinical manifestations of ocular graft-versus-host disease following hematopoietic stem cell transplantation.
Bone Marrow Transplant. 2024 May 31. doi: 10.1038/s41409-024-02321.
PubMed Abstract available

FERNANDEZ-SOJO J, Azqueta C, Valdivia E, Martorell L, et al
Correction: Cryopreservation of unrelated donor hematopoietic stem cells: the right answer for transplantations during the COVID-19 pandemic?
Bone Marrow Transplant. 2024 May 28. doi: 10.1038/s41409-024-02318.
PubMed

TERAO T, Matsuoka KI, Fuji S, Kawamura S, et al
Association between human herpesvirus-6 encephalitis and antiviral prophylaxis after allogeneic hematopoietic stem cell transplantation in the letermovir era.
Bone Marrow Transplant. 2024 May 25. doi: 10.1038/s41409-024-02313.
PubMed Abstract available

XHAARD A, Floch A, Ruggiu M, Robin M, et al
Donor/recipient Rh-mismatched allogeneic hematopoietic stem cell transplantation: transfusion strategy and allo-immunization to red blood cell antigens.
Bone Marrow Transplant. 2024 May 25. doi: 10.1038/s41409-024-02316.
PubMed Abstract available

ROBIN M, Nibourel O, Tournaire M, Michonneau D, et al
Molecular alterations monitoring in myelodysplastic patients receiving an allogeneic hematopoietic stem cell transplantation after a reduced-intensity conditioning regimen.
Bone Marrow Transplant. 2024 May 23. doi: 10.1038/s41409-024-02314.
PubMed

HU X, Wang Z, Qin Y, Xu J, et al
Allogeneic haematopoietic stem cell transplantation might overcome the poor prognosis of adolescents and adult patients with T-lineage acute lymphoblastic leukaemia and CDKN2 deletion.
Bone Marrow Transplant. 2024 May 20. doi: 10.1038/s41409-024-02306.
PubMed Abstract available

PARK B, Pires K, Jian CY, Sano L, et al
A library of TikToks to engage diverse populations to hematopoietic stem cell donation.
Bone Marrow Transplant. 2024 May 16. doi: 10.1038/s41409-024-02294.
PubMed

MORA E, Montoro J, Balaguer A, Rovira M, et al
Total body irradiation versus thiotepa/busulfan-based conditioning regimens for myeloablative allogeneic stem cell transplantation in adults with acute lymphoblastic leukemia.
Bone Marrow Transplant. 2024 May 16. doi: 10.1038/s41409-024-02298.
PubMed Abstract available

ROBIN M, Iacobelli S, Koster L, Passweg J, et al
Correction: Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT.
Bone Marrow Transplant. 2024 May 13. doi: 10.1038/s41409-024-02293.
PubMed

PEREZ A, Gomez D, Montoro J, Chorao P, et al
Are any specific respiratory viruses more severe than others in recipients of allogeneic stem cell transplantation? A focus on lower respiratory tract disease.
Bone Marrow Transplant. 2024 May 10. doi: 10.1038/s41409-024-02304.
PubMed Abstract available

SINANIDIS I, Hochman MJ, Tsai HL, Randall MP, et al
Favorable outcomes in MDS and oligoblastic AML-MR after reduced-intensity conditioning allogeneic bone marrow transplantation with post-transplantation cyclophosphamide.
Bone Marrow Transplant. 2024 May 7. doi: 10.1038/s41409-024-02299.
PubMed

BERNING P, Kolloch L, Reicherts C, Call S, et al
Comparable outcomes for TBI-based versus treosulfan based conditioning prior to allogeneic hematopoietic stem cell transplantation in AML and MDS patients.
Bone Marrow Transplant. 2024 May 3. doi: 10.1038/s41409-024-02295.
PubMed Abstract available

AYUK F, Wagner-Drouet EM, Wolff D, von Huenerbein N, et al
Treatment of newly diagnosed moderate or severe chronic graft-versus-host disease with prednisone and everolimus (PredEver first): a prospective multicenter phase IIA study.
Bone Marrow Transplant. 2024 May 2. doi: 10.1038/s41409-024-02289.
PubMed Abstract available

April 2024

DAVIDOV Y, Shem-Tov N, Yerushalmi R, Hod T, et al
Liver stiffness measurements predict Sinusoidal Obstructive Syndrome after hematopoietic stem cell transplantation.
Bone Marrow Transplant. 2024 Apr 24. doi: 10.1038/s41409-024-02288.
PubMed Abstract available

XU W, Chen W, Guo J, Zhao L, et al
Acute kidney injury during autologous stem cell transplantation in light chain amyloidosis with kidney involvement and their impact on prognosis.
Bone Marrow Transplant. 2024 Apr 24. doi: 10.1038/s41409-024-02292.
PubMed Abstract available

ALSUHEBANY N, Alshehri B, Aldairem A, Aleissa MM, et al
Herpes simplex virus reactivation among hematopoietic stem cell transplant recipients: re-evaluating acyclovir dosage.
Bone Marrow Transplant. 2024 Apr 16. doi: 10.1038/s41409-024-02273.
PubMed

NAGLER A, Labopin M, Swoboda R, Schroeder T, et al
Post-transplant cyclophosphamide, calcineurin inhibitor, and mycophenolate mofetil compared to anti-thymocyte globulin, calcineurin inhibitor, and methotrexate combinations as graft-versus-host disease prophylaxis post allogeneic stem cell transplanta
Bone Marrow Transplant. 2024 Apr 13. doi: 10.1038/s41409-024-02284.
PubMed Abstract available

SHEN Y, Liu M, Shen D, Chu M, et al
Busulfan plus cyclophosphamide vs. total body irradiation plus cyclophosphamide for allogeneic hematopoietic stem cell transplantation in patients with acute T lymphoblastic leukemia: a large-scale propensity score matching-based study.
Bone Marrow Transplant. 2024 Apr 13. doi: 10.1038/s41409-024-02280.
PubMed

TAHMAZ V, Menghesha L, Stern ME, Holtick U, et al
Insulin eye drops for severe refractory chronic ocular graft-versus-host disease.
Bone Marrow Transplant. 2024 Apr 10. doi: 10.1038/s41409-024-02272.
PubMed

WANG L, Xu G, Wang L, Jiang J, et al
Post-transplant cyclophosphamide at 80 mg/kg with low dose post-engraftment anti-thymocyte globulin in haploidentical transplantation with myeloablative conditioning.
Bone Marrow Transplant. 2024 Apr 10. doi: 10.1038/s41409-024-02277.
PubMed Abstract available

FILIOGLOU D, Truscott L, Reddivalla N, Katsanis E, et al
Outcomes of haploidentical bone marrow transplantation in infant acute leukemia: a single center experience.
Bone Marrow Transplant. 2024 Apr 9. doi: 10.1038/s41409-024-02281.
PubMed

ZHANG X, Zhao X, Chen S, Hao M, et al
Addition of ruxolitinib to standard graft-versus-host disease prophylaxis for allogeneic stem cell transplantation in aplastic anemia patients.
Bone Marrow Transplant. 2024 Apr 5. doi: 10.1038/s41409-024-02266.
PubMed Abstract available

MA R, Zhu DP, Zhang XH, Xu LP, et al
Salvage haploidentical transplantation for graft failure after first haploidentical allogeneic stem cell transplantation: an updated experience.
Bone Marrow Transplant. 2024 Apr 2. doi: 10.1038/s41409-024-02276.
PubMed Abstract available

March 2024

KOO RM, Wong E, Davis JE, Perera T, et al
A phase 1 dose-escalation study of low-dose lenalidomide maintenance post-allogeneic stem cell transplantation for high-risk acute myeloid leukaemia or myelodysplastic syndrome.
Bone Marrow Transplant. 2024 Mar 27. doi: 10.1038/s41409-023-02195.
PubMed

ESTRAN S, Loschi M, Benachour S, Soldati A, et al
Improving nutritional status after allogeneic stem cell transplantation: results of phase 2 ALLONUT clinical trial.
Bone Marrow Transplant. 2024 Mar 20. doi: 10.1038/s41409-024-02271.
PubMed Abstract available

GUIEZE R, Eikema DJ, Koster L, Schetelig J, et al
Allogeneic hematopoietic stem-cell transplantation for patients with Richter transformation: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT.
Bone Marrow Transplant. 2024 Mar 19. doi: 10.1038/s41409-024-02256.
PubMed Abstract available

YADAV H, Herasevich S, Zhang Z, White BA, et al
Pulmonary function as a continuum of risk: critical care utilization and survival after allogeneic hematopoietic stem cell transplantation - a multicenter cohort study.
Bone Marrow Transplant. 2024 Mar 16. doi: 10.1038/s41409-024-02265.
PubMed Abstract available

ROBIN M, Iacobelli S, Koster L, Passweg J, et al
Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT.
Bone Marrow Transplant. 2024 Mar 15. doi: 10.1038/s41409-024-02269.
PubMed Abstract available

FURST S, Bernit E, Legrand F, Granata A, et al
Durable engraftment after pharmacological pre-transplant immune suppression followed by reduced-toxicity myeloablative haploidentical stem cell transplantation in highly HLA-immunized adults with sickle cell disease.
Bone Marrow Transplant. 2024 Mar 14. doi: 10.1038/s41409-024-02257.
PubMed Abstract available

SAUER S, Engelhardt M, Trautmann-Grill K, Kimmich C, et al
Treatment pattern and outcomes of re-induction therapy prior to stem cell transplantation in patients with relapsed/refractory multiple myeloma in Germany.
Bone Marrow Transplant. 2024 Mar 14. doi: 10.1038/s41409-024-02208.
PubMed Abstract available

MORRIS SL, Thomas BR, Palanicawandar R, Whittaker S, et al
Long term outcomes of nonmyeloablative allogeneic stem cell transplantation with TSEB TLI and ATG for Mycosis Fungoides and Sezary Syndrome.
Bone Marrow Transplant. 2024 Mar 12. doi: 10.1038/s41409-024-02236.
PubMed Abstract available

FRAEBEL J, Park S, Shah R, Prieto-Granada C, et al
GVHD like skin eruption post-autologous stem cell transplantation.
Bone Marrow Transplant. 2024 Mar 11. doi: 10.1038/s41409-024-02259.
PubMed

FAZIO F, Passucci M, Micozzi J, Di Landro F, et al
Effect of daratumumab on stem cell yields in patients with newly diagnosed multiple myeloma: a report from the Multiple Myeloma Group.
Bone Marrow Transplant. 2024 Mar 9. doi: 10.1038/s41409-024-02260.
PubMed

DACHY G, Vankeerbergen M, Vanlangendonck N, Straetmans N, et al
Von Willebrand factor as a potential predictive biomarker of early complications of endothelial origin after allogeneic hematopoietic stem cell transplantation.
Bone Marrow Transplant. 2024 Mar 8. doi: 10.1038/s41409-024-02242.
PubMed

CHU SC, Hsieh CJ, Li CC, Yang SH, et al
Long-term follow-up of cancer and catastrophic diseases in hematopoietic stem cell donors: a comprehensive matched cohort study.
Bone Marrow Transplant. 2024 Mar 7. doi: 10.1038/s41409-024-02204.
PubMed Abstract available

SHANG Q, Bai L, Cheng Y, Suo P, et al
Outcomes and prognosis of haploidentical haematopoietic stem cell transplantation in children with FLT3-ITD mutated acute myeloid leukaemia.
Bone Marrow Transplant. 2024 Mar 5. doi: 10.1038/s41409-024-02214.
PubMed Abstract available

PARK S, Bang SY, Kwag D, Lee JH, et al
Reduced toxicity (FluBu3) versus myeloablative (BuCy) conditioning in acute myeloid leukemia patients who received first allogeneic hematopoietic stem cell transplantation in measurable residual disease-negative CR1.
Bone Marrow Transplant. 2024 Mar 4. doi: 10.1038/s41409-024-02255.
PubMed Abstract available

February 2024

YANG YM, Guo SJ, Xiao R, Yu XJ, et al
Prevalence of osteoporosis among patients after stem cell transplantation: a systematic review and meta-analysis.
Bone Marrow Transplant. 2024 Feb 29. doi: 10.1038/s41409-024-02243.
PubMed Abstract available

BACCELLI F, Gottardi F, Muratore E, Leardini D, et al
Ruxolitinib for the treatment of acute and chronic graft-versus-host disease in children: a systematic review and individual patient data meta-analysis.
Bone Marrow Transplant. 2024 Feb 24. doi: 10.1038/s41409-024-02252.
PubMed Abstract available

FINAZZI MC, Weber A, Pavoni C, Grassi A, et al
Rituximab added to conditioning regimen significantly improves erythroid engraftment in major incompatible ABO-group hematopoietic stem cell transplantation.
Bone Marrow Transplant. 2024 Feb 24. doi: 10.1038/s41409-024-02247.
PubMed Abstract available

MURRAY A, Linn SM, Yu B, Novitzky-Basso I, et al
Real-world experience with ruxolitinib therapy for steroid-refractory acute graft versus host disease.
Bone Marrow Transplant. 2024 Feb 24. doi: 10.1038/s41409-024-02249.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Stem Cell Research is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum